You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ficlatuzumab

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer Trial in Boston (Gemcitabine, Nab-paclitaxel, Ficlatuzumab)

Completed
  • Pancreatic Cancer
  • Boston, Massachusetts
  • +1 more
Aug 1, 2021

Acute Myeloid Leukemia Trial (Ficlatuzumab, Cytarabine)

Withdrawn
  • Acute Myeloid Leukemia
  • (no location specified)
Mar 27, 2020

Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in San Francisco (Ficlatuzumab,

Terminated
  • Acute Myeloid Leukemia
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Mar 22, 2020

NSCLC Trial in Worldwide (Ficlatuzumab, Erlotinib, )

Terminated
Has Results
  • Non-small Cell Lung Cancer
  • Ficlatuzumab
  • +2 more
  • Fresno, California
  • +46 more
Oct 20, 2020

Carcinoma, Squamous Cell of Head and Neck, Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma, Head And Neck

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • +2 more
  • Pittsburgh, Pennsylvania
  • +2 more
Apr 16, 2019

Carcinoma, Squamous Cell of Head and Neck Trial in Pittsburgh (Ficlatuzumab, Cisplatin, Intensity Modulated Radiotherapy (IMRT))

Terminated
  • Carcinoma, Squamous Cell of Head and Neck
  • Ficlatuzumab
  • +2 more
  • Pittsburgh, Pennsylvania
  • +2 more
Nov 8, 2017